These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
565 related articles for article (PubMed ID: 9267827)
21. Wide resection of primary tumors of bone and replacement with massive bone grafts: an improved technique for transplanting allogeneic bone grafts. Koskinen EV Clin Orthop Relat Res; 1978; (134):302-19. PubMed ID: 365415 [TBL] [Abstract][Full Text] [Related]
22. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors. Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544 [TBL] [Abstract][Full Text] [Related]
23. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482 [TBL] [Abstract][Full Text] [Related]
24. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas. Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142 [TBL] [Abstract][Full Text] [Related]
25. [An analysis of autopsy cases of malignant soft tissue and bone tumors]. Enjoji M; Hashimoto H; Yamamoto I; Daimaru Y Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1931-6. PubMed ID: 2543328 [TBL] [Abstract][Full Text] [Related]
26. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984 [TBL] [Abstract][Full Text] [Related]
27. Expression of hepatocyte growth factor and c-MET in skull base chordoma. Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912 [TBL] [Abstract][Full Text] [Related]
28. Matrix vesicles in bone tumors. Ultrastructural analysis and their significance in neoplastic bone formation. Yoshida H; Miyazaki S; Yumoto T Acta Pathol Jpn; 1991 Aug; 41(8):610-7. PubMed ID: 1661059 [TBL] [Abstract][Full Text] [Related]
29. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein. Ostroumov E; Hunter CJ Spine (Phila Pa 1976); 2008 Dec; 33(25):2774-80. PubMed ID: 19050584 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163 [TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
32. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution. Baena-Ocampo Ldel C; Ramirez-Perez E; Linares-Gonzalez LM; Delgado-Chavez R Ann Diagn Pathol; 2009 Feb; 13(1):16-21. PubMed ID: 19118777 [TBL] [Abstract][Full Text] [Related]
33. Role of protein phosphatase in malignant osteogenic and soft tissue tumors. Sogawa K; Yamada T; Sugita A; Kito K; Tachibana M; Nezu K; Ueda N Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):33-42. PubMed ID: 8865368 [TBL] [Abstract][Full Text] [Related]
34. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055 [TBL] [Abstract][Full Text] [Related]
35. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors. Amling M; Pösl M; Hentz MW; Priemel M; Delling G Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428 [TBL] [Abstract][Full Text] [Related]
36. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade. Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578 [TBL] [Abstract][Full Text] [Related]
37. MR imaging of primary bone tumors and tumor-like conditions in children. Wootton-Gorges SL Magn Reson Imaging Clin N Am; 2009 Aug; 17(3):469-87, vi. PubMed ID: 19524197 [TBL] [Abstract][Full Text] [Related]
38. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols. Ahmed A; Gilbert-Barness E; Lacson A Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930 [TBL] [Abstract][Full Text] [Related]
39. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors. Hu B; McPhaul L; Cornford M; Gaal K; Mirra J; French SW Am J Clin Pathol; 1999 Aug; 112(2):189-93. PubMed ID: 10439798 [TBL] [Abstract][Full Text] [Related]
40. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study. Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]